Laurus Labs gets EIR from USFDA for Andhra Pradesh manufacturing facility

15 Jun 2023 Evaluate

Laurus Labs has received the Establishment Inspection Report (EIR) from United States Food and Drug Administration (USFDA) for its formulations manufacturing facility Unit–2, APSEZ, Atchutapuram, Visakhapatnam, Andhra Pradesh.  Earlier, USFDA had conducted inspection at the said manufacturing unit from February 06, 2023 to February 10, 2023. 

Laurus Labs is a leading research and development driven pharmaceutical company in India. The company has grown consistently to become one of the leading manufacturers of APIs for anti-retroviral (ARV) and Hepatitis C. It also manufactures APIs in oncology and other therapeutic areas.

Laurus Labs Share Price

512.45 23.40 (4.78%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.